Overview
This study aims to understand whether it is possible to predict the effectiveness of maintenance treatment with PARP inhibitors following first-line chemotherapy in ovarian cancer, and thus better target the patients who benefit from this treatment
Eligibility
Inclusion Criteria: Patients randomised in the PAOLA-1 study -
Exclusion Criteria:Opposition to the use of your data for research purposes.
-